Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
Public ClinicalTrials.gov record NCT03937869. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Open-Label Study to Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g Oral Granules for the Treatment of Adolescent Girls With Bacterial Vaginosis
Study identification
- NCT ID
- NCT03937869
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Lupin Research Inc
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Secnidazole Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 27, 2018
- Primary completion
- Nov 4, 2020
- Completion
- Nov 4, 2020
- Last update posted
- Dec 18, 2020
2018 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 1004 - Investigational Research Center | Long Beach | California | 90806 | — |
| Site 1005 - Investigational Research Center | Hialeah | Florida | 33016 | — |
| Site 1001 - Investigational Research Center | Miami Lakes | Florida | 33161 | — |
| Site 1010 - Investigational Research Center | Sarasota | Florida | 34239 | — |
| Site 1013 | Tampa | Florida | 33613 | — |
| Site 1011 - Investigational Research Center | Bardstown | Kentucky | 40004 | — |
| Site 1008 - Investigational Research Center | Saginaw | Michigan | 48604 | — |
| Site 1007 - Investigational Research Center | Memphis | Tennessee | 38104 | — |
| Site 1006 - Investigational Research Center | Frisco | Texas | 75035 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03937869, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03937869 live on ClinicalTrials.gov.